Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:AEX CVE:BOR NYSE:ECO NASDAQ:PHAR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEXAEX GoldC$0.62-1.6%C$0.62C$0.44▼C$0.82C$109.80MN/A28,496 shs8,500 shsBORBorder PetroleumC$0.01-33.3%C$0.01C$0.01▼C$0.04C$637KN/A236,078 shs25,000 shsECOOkeanis Eco Tankers$25.59-1.1%$23.47$17.91▼$35.64$833.18M-0.13136,839 shs116,200 shsPHARPharming Group$11.38+1.2%$10.88$6.73▼$17.08$770.79M0.0211,056 shs10,143 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEXAEX Gold0.00%0.00%0.00%0.00%0.00%BORBorder Petroleum0.00%0.00%0.00%0.00%0.00%ECOOkeanis Eco Tankers+4.75%+2.47%+10.48%+7.96%-14.44%PHARPharming Group-0.44%-8.46%+8.70%+23.22%+51.62%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEXAEX GoldN/AN/AN/AN/AN/AN/AN/AN/ABORBorder PetroleumN/AN/AN/AN/AN/AN/AN/AN/AECOOkeanis Eco Tankers4.2165 of 5 stars3.55.02.50.02.40.01.3PHARPharming Group2.8563 of 5 stars3.55.00.00.02.50.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEXAEX Gold 0.00N/AN/AN/ABORBorder Petroleum 0.00N/AN/AN/AECOOkeanis Eco Tankers 3.00Buy$34.5034.83% UpsidePHARPharming Group 3.00Buy$30.00163.62% UpsideCurrent Analyst Ratings BreakdownLatest ECO, BOR, PHAR, and AEX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/23/2025ECOOkeanis Eco TankersJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$29.00(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEXAEX GoldN/AN/AC$0.13 per share4.59C$0.21 per shareN/ABORBorder PetroleumC$1.31M0.49N/AN/AC($0.02) per share-0.63ECOOkeanis Eco Tankers$393.23M2.09$4.56 per share5.61$13.30 per share1.92PHARPharming Group$297.20M2.62$0.07 per share151.76$3.50 per share3.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEXAEX GoldN/A-C$0.14N/A∞N/AN/AN/AN/AN/ABORBorder PetroleumN/A-C$0.02N/A∞N/AN/AN/AN/AN/AECOOkeanis Eco Tankers$108.86M$2.4812.24∞N/A19.52%15.81%6.07%N/APHARPharming Group-$11.84M-$0.13N/A379.33N/A-2.19%-3.31%-1.78%10/23/2025 (Estimated)Latest ECO, BOR, PHAR, and AEX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025ECOOkeanis Eco Tankers$0.46$0.83+$0.37$0.84$56.10 million$93.95 million7/31/2025Q2 2025PHARPharming Group-$0.10$0.06+$0.16$0.06$70.36 million$93.20 million5/14/2025Q1 2025ECOOkeanis Eco Tankers$0.24$0.36+$0.12$0.39$46.91 million$48.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEXAEX GoldN/AN/AN/AN/AN/ABORBorder PetroleumN/AN/AN/AN/AN/AECOOkeanis Eco Tankers$1.285.00%N/A51.61%N/APHARPharming GroupN/AN/AN/AN/AN/ALatest ECO, BOR, PHAR, and AEX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/31/2025ECOOkeanis Eco Tankers$0.329.52%6/3/20256/4/20256/12/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEXAEX Gold2.0919.9019.77BORBorder PetroleumN/A0.600.60ECOOkeanis Eco Tankers1.431.651.28PHARPharming Group0.382.792.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEXAEX GoldN/ABORBorder PetroleumN/AECOOkeanis Eco TankersN/APHARPharming Group0.03%Insider OwnershipCompanyInsider OwnershipAEXAEX GoldN/ABORBorder PetroleumN/AECOOkeanis Eco TankersN/APHARPharming Group2.07%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEXAEX GoldN/A177.10 millionN/ANot OptionableBORBorder PetroleumN/A63.69 millionN/ANot OptionableECOOkeanis Eco Tankers1432.19 millionN/AN/APHARPharming Group28068.51 million67.10 millionNot OptionableECO, BOR, PHAR, and AEX HeadlinesRecent News About These CompaniesPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?August 13 at 1:34 PM | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Should You Sell?August 12 at 2:53 PM | marketbeat.comPharming Group NV (PHARMA.XD) - Yahoo FinanceAugust 10, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Hits New 1-Year High - Still a Buy?August 7, 2025 | marketbeat.comWall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a BetAugust 6, 2025 | zacks.comPharming Group (NASDAQ:PHAR) Trading Up 7.9% - Should You Buy?August 5, 2025 | marketbeat.comPharming Group N.V. Reports Strong Q2 EarningsAugust 4, 2025 | theglobeandmail.comPharming Group to participate in August investor conferenceAugust 4, 2025 | uk.finance.yahoo.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume Following Better-Than-Expected EarningsAugust 2, 2025 | marketbeat.comPharming Group Second Quarter 2025 Earnings: EPS: US$0.007 (vs US$0.002 loss in 2Q 2024)August 2, 2025 | finance.yahoo.comPharming Group N.V. (PHAR) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | seekingalpha.comPharming Group N.V. 2025 Q2 - Results - Earnings Call PresentationAugust 1, 2025 | seekingalpha.comPharming Group (NASDAQ:PHAR) Shares Gap Up After Better-Than-Expected EarningsAugust 1, 2025 | marketbeat.comNew Strong Buy Stocks for August 1stAugust 1, 2025 | zacks.comPharming Group reports second quarter and first half 2025 financial results and provides business updateJuly 31, 2025 | finance.yahoo.comHigh Growth Tech Stocks To Watch In Europe July 2025July 29, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Still a Buy?July 26, 2025 | marketbeat.comBest Momentum Stocks to Buy for July 25thJuly 25, 2025 | zacks.comNew Strong Buy Stocks for July 25thJuly 25, 2025 | zacks.comPharming Group (PHAR) Projected to Post Quarterly Earnings on ThursdayJuly 24, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Down 4.7% - What's Next?July 22, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025AMD Just Triggered a Signal Traders Can’t IgnoreBy Thomas Hughes | July 16, 2025IPO Market Stays Hot With These 2 Debuting StocksBy Dan Schmidt | August 11, 2025D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?By Nathan Reiff | July 28, 20253 High-Risk, High-Reward Stocks With Explosive UpsideBy Nathan Reiff | July 16, 2025ECO, BOR, PHAR, and AEX Company DescriptionsAEX Gold CVE:AEXC$0.62 -0.01 (-1.59%) As of 07/11/2022AEX Gold Inc. engages in the acquisition, exploration, and development of mineral properties in Greenland. It holds interests in licenses covering an area of 7,615.85 square kilometers located in South Greenland. The company was formerly known as Alopex Gold Inc. and changed its name to AEX Gold Inc. in June 2018. AEX Gold Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.Border Petroleum CVE:BORC$0.01 -0.01 (-33.33%) As of 07/30/2018Border Petroleum Limited engages in the acquisition, exploration, development, and production of crude oil, natural gas and, natural gas liquids in the province of Alberta, Canada. The company holds working interests in 520 gross acres in the Norris area of central Alberta, as well as in five producing oil wells and one water disposal well; 9,647 gross acres in the Mulligan area; 3,170 gross acres in the Cherhill area of southwestern Alberta; and 11,070 gross acres in the Blueridge area. It also holds a non-operated interest in the Chip Lake property. The company is based in Calgary, Canada.Okeanis Eco Tankers NYSE:ECO$25.59 -0.29 (-1.13%) Closing price 03:59 PM EasternExtended Trading$25.05 -0.54 (-2.12%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Okeanis Eco Tankers Corp., a shipping company, owns and operates tanker vessels worldwide. It operates a fleet of 14 tanker vessels comprising six modern Suezmax tankers and eight modern VLCC tankers focusing on the transportation of crude oil. The company was incorporated in 2018 and is based in Neo Faliro, Greece.Pharming Group NASDAQ:PHAR$11.38 +0.13 (+1.16%) Closing price 03:59 PM EasternExtended Trading$11.34 -0.04 (-0.40%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Deere’s Sell-Off Could Be a Long-Term Buying Chance Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go? Mercury Systems Up 27%: Financials Send Investors a Clear Signal Brinker Serves Up Earnings Beat, Sidesteps Cost Pressures CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.